DE183712C - - Google Patents

Info

Publication number
DE183712C
DE183712C DENDAT183712D DE183712DA DE183712C DE 183712 C DE183712 C DE 183712C DE NDAT183712 D DENDAT183712 D DE NDAT183712D DE 183712D A DE183712D A DE 183712DA DE 183712 C DE183712 C DE 183712C
Authority
DE
Germany
Prior art keywords
blooded
tubercle bacilli
warm
bacilli
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT183712D
Other languages
German (de)
English (en)
Publication of DE183712C publication Critical patent/DE183712C/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1289—Mycobacteriaceae (F)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DENDAT183712D Active DE183712C (enExample)

Publications (1)

Publication Number Publication Date
DE183712C true DE183712C (enExample)

Family

ID=447702

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT183712D Active DE183712C (enExample)

Country Status (1)

Country Link
DE (1) DE183712C (enExample)

Similar Documents

Publication Publication Date Title
DE2217817C2 (de) Pharmazeutisches Präparat zur Behandlung von oder zum Schutz gegen autoimmune Erkrankungen, die das Gehirn angreifen
Thomas et al. The effect of cortisone on the Shwartzman reaction: The production of lesions resembling the dermal and generalized Shwartzman reactions by a single injection of bacterial toxin in cortisone-treated rabbits
EP0585552A1 (de) Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
Flexner The histological changes produced by ricin and abrin intoxications
CH414063A (de) Röntgenkontrastmittel
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
Hottendorf et al. Canine mastocytoma: I. Blood coagulation time in dogs with mastocytoma
DE183712C (enExample)
Sonobe et al. Silkworm Bombyx mori L.: nature of diapause factor
DE191752C (enExample)
DE69227618T2 (de) Die verwendung des leukozyten adhäsionsmolekül-1- aus endothelzellen und antikörper dagegen in der behandlung von asthma
DE3032606C2 (de) Polysaccharidderivat der Streptokinase, Verfahren zu dessen Herstellung und Anwendung
DE1902590C2 (de) Verwendung einer Immunribonucleinsäure (IRNS) zum Immunisieren lebender Tiere
DE940315C (de) Verfahren zur Herstellung von Lymphe gegen Schweinepest
DE69032158T2 (de) Wachstumsinhibitor von tumorzellen
Bonventre et al. An autoradiographic study of anthrax infection in the mouse
CH667204A5 (de) Pharmazeutisches praeparat enthaltend lebende vermehrungsfaehige embryonalzellen, verfahren zu dessen herstellung und verfahren zum testen der pharmazeutischen wirksamkeit.
DE238162C (enExample)
DE1617538C3 (de) Verfahren zur Herstellung von Tetanus-Antitoxin
Kirk Demodectic mange
DE2004869C2 (de) Verwendung einer in üblicher Weise gewonnenen i-RNS zur Antikörper-Bildung
DE116622C (enExample)
DE257473C (enExample)
Van Dyke et al. A Study of the Standardization of Digitalis. II. The Relationship Between Laboratory Methods of Assay and Potency as Determined by Experimental Cumulative Poisoning and Clinical Standardization
AT264713B (de) Verfahren zur Herstellung von perkutan verwendbaren Dispersionen